Skip to content

Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations

Evaluation of Corneal Staining With Market Contact Lens/Solution Combinations

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00381446
Enrollment
200
Registered
2006-09-27
Start date
2005-07-31
Completion date
2008-03-31
Last updated
2007-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Epithelial Disruption, Corneal Staining

Keywords

corneal staining, contact lens care, multipurpose solution

Brief summary

The purpose of this study is to quantify the amount of corneal staining observed with various marketed contact lens/multipurpose solution combinations. The hypothesis is that there are measurable differences in the amount of corneal staining between the various combinations.

Detailed description

A series of clinical studies is being conducted at one research site using a double-masked, randomized cross-over design. Each study consists of asymptomatic daily wear soft contact lens wearers observed at baseline and at two and four hours post lens insertion. Corneal staining is being assessed using sodium fluorescein, a cobalt filter and a yellow filter. Subjective comfort assessments are obtained at each visit.

Interventions

DEVICEMarketed contact lens care products

Sponsors

Alcon Research
CollaboratorINDUSTRY
Andrasko, Gary, OD, LLC
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* currently wearing soft contact lenses daily wear for at least 2 weeks prior to study * correct visual acuity of 20/30 or better each eye

Exclusion criteria

* history of hypersensitivity to any components of solution being tested * any ocular condition prohibiting contact lens wear * excessive baseline staining as defined in protocol * use of topical or OTC ocular medications during the study * seasonal allergies with significant effect on contact lens wear

Design outcomes

Primary

MeasureTime frame
Area of Corneal Staining

Secondary

MeasureTime frame
Type (severity) of Corneal Staining

Countries

United States

Contacts

Primary ContactGary J. Andrasko, OD, MS
gandrask@columbus.rr.com614-459-3363

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026